Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase

被引:16
|
作者
Jiang, Y. [1 ,3 ]
Ng, T. B. [2 ]
Wang, C. R. [1 ]
Zhang, D. [1 ]
Cheng, Z. H. [1 ]
Liu, Z. K. [1 ]
Qiao, W. T. [3 ]
Geng, Y. Q. [3 ]
Li, N. [1 ]
Liu, F. [1 ,3 ]
机构
[1] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin 300071, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China
[3] Nankai Univ, Ctr AIDS Res, Tianjin 300071, Peoples R China
关键词
HIV-1; RT; PR; IN; natural products; HUMAN-IMMUNODEFICIENCY-VIRUS; BIOLOGICAL-PROPERTIES; ANTIFUNGAL PROTEIN; FUNGAL METABOLITE; MEDICINAL-PLANTS; AGASTACHE-RUGOSA; BINDING LECTIN; MUSHROOM; ACID; TRITERPENOIDS;
D O I
10.2174/138955710793564133
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus type 1 (HIV-1) infection, is still one of the most challenging diseases of the early 21st century. Reverse transcriptase (RT), protease (PR) and integrase (IN) are three key enzymes of HIV-1. Despite the shortcomings of chemical drugs such as toxicity, lack of curative and multiple effects, the search for more and better anti-HIV agents has been focused on natural products. Many natural products have been shown to possess promising activities that could assist in the prevention and amelioration of the disease. Most of these natural anti-HIV agents have other medicinal values as well, which afford them further prospective as novel lead compounds for the development of new drugs. These natural products can deal with both the virus and the various disorders that are caused by HIV. In this review, natural inhibitors of RT, PR and IN have been found to be classified and the relationship between structure and inhibitory activity is discussed.
引用
收藏
页码:1331 / 1344
页数:14
相关论文
共 50 条
  • [1] HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
    Rhee, Soo-Yon
    Sankaran, Kris
    Varghese, Vici
    Winters, Mark A.
    Hurt, Christopher B.
    Eron, Joseph J.
    Parkin, Neil
    Holmes, Susan P.
    Holodniy, Mark
    Shafer, Robert W.
    JOURNAL OF VIROLOGY, 2016, 90 (13) : 6058 - 6070
  • [2] Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase
    de Soultrait, VR
    Desjobert, C
    Tarrago-Litvak, L
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (18) : 1765 - 1778
  • [3] OLIGONUCLEOTIDE CONJUGATES AS INHIBITORS OF HIV-1 INTEGRASE AND REVERSE TRANSCRIPTASE
    Zatsepin, T.
    Agapkina, J.
    Korolev, S.
    Gottikh, M.
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A31 - A31
  • [4] Oligonucleotide Inhibitors of HIV-1 Integrase Efficiently Inhibit HIV-1 Reverse Transcriptase
    Korolev, S. P.
    Zatsepin, T. S.
    Gottikh, M. B.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 135 - 139
  • [5] Oligonucleotide inhibitors of HIV-1 integrase efficiently inhibit HIV-1 reverse transcriptase
    S. P. Korolev
    T. S. Zatsepin
    M. B. Gottikh
    Russian Journal of Bioorganic Chemistry, 2017, 43 : 135 - 139
  • [6] Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase:: A single mode of inhibition for the three HIV enzymes?
    Camarasa, Maria-Jose
    Velazquez, Sonsoles
    San-Felix, Ana
    Perez-Perez, Maria-Jesus
    Gago, Federico
    ANTIVIRAL RESEARCH, 2006, 71 (2-3) : 260 - 267
  • [7] Control of viral replication following transmission of HIV-1 exhibiting resistance to reverse transcriptase, protease and integrase inhibitors
    Fransen, S.
    Young, B.
    Frantzell, A.
    Greenberg, K.
    Thomas, A.
    Martens, S.
    St Clair, M.
    Ha, B.
    Huang, W.
    Petropoulos, C. J.
    ANTIVIRAL THERAPY, 2010, 15 : A67 - A67
  • [8] Inhibitors of HIV-1 reverse transcriptase and integrase: Classical and emerging therapeutical approaches
    Tarrago-Litvak, L
    Andreola, ML
    Fournier, M
    Nevinsky, GA
    Parissi, V
    de Soultrait, VR
    Litvak, S
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (08) : 595 - 614
  • [9] Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase
    Gu, Shuang-Xi
    Xue, Ping
    Ju, Xiu-Lian
    Zhu, Yuan-Yuan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5007 - 5016
  • [10] Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease
    Yasuno, Takumi
    Ohe, Tomoyuki
    Kataoka, Hiroki
    Hashimoto, Kosho
    Ishikawa, Yumiko
    Furukawa, Keigo
    Tateishi, Yasuhiro
    Kobayashi, Toi
    Takahashi, Kyoko
    Nakamura, Shigeo
    Mashino, Tadahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31